🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
GER
$GERN
🔒 US EquitiesGeron Corp
AVG HISTORICAL GAP
-2.36%
MAX GAP RECORD
-27.00%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $GERN
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$GERN
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Nov 04, 2026 Earnings Release 2026-11-04 (BEFORE OPEN (07:00)) | 🔮 UPCOMING 🔒 |
| Aug 05, 2026 Earnings Release 2026-08-05 (BEFORE OPEN) |
+2.24%
|
| May 06, 2026 Earnings Release 2026-05-06 (BEFORE OPEN) |
+0.61%
|
| Feb 25, 2026 Earnings Release 2026-02-25 (BEFORE OPEN) |
-13.85%
|
| Nov 05, 2025 Earnings Release 2025-11-05 (BEFORE OPEN) |
-4.35%
|
| Aug 06, 2025 Earnings Release 2025-08-06 (BEFORE OPEN) |
+8.33%
|
| May 07, 2025 Earnings Release 2025-05-07 (BEFORE OPEN) |
-1.52%
|
| Feb 26, 2025 Earnings Release 2025-02-26 (BEFORE OPEN) |
-27.00%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
5.2%
Bullish Gaps (5)
Bearish Gaps (7)
Neutral / Flat (2)
📖 Intelligence Summary
Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗